| Popis: |
Additional file 1: Table S1. Country-level percentage coverage of Bacillus Calmette–Guérin (BCG) vaccination in 2019, by age group. Table S2. Country-level dates of implementation of non-pharmaceutical interventions. Figure S1. Schematic overview of the Imperial College London (ICL) model adopted in this study [11]. Figure S2. Country-level estimates of infections, deaths and Rt in Ethiopia. Scenarios: A) The population is not BCG vaccinates, homogenous and not structured by age; B) BCG vaccinated population aged 39 years and below; C) BCG vaccinated population aged 40 years and above. Top: daily number of infections, brown bars are reported infections, blue bands are predicted infections, dark blue 50% credible interval (CI), light blue 95% CI. Bottom-left: daily number of deaths, brown bars are reported deaths, blue bands are predicted deaths. Bottom-right: time-varying reproduction number (Rt), dark-green 50% CI, light-green 95% CI. Figure S3. Country-level estimates of infections, deaths and Rt in Kenya. Scenarios: A) The population is not BCG vaccinates, homogenous and not structured by age; B) BCG vaccinated population aged 39 years and below; C) BCG vaccinated population aged 40 years and above. Top: daily number of infections, brown bars are reported infections, blue bands are predicted infections, dark blue 50% credible interval (CI), light blue 95% CI. Bottom-left: daily number of deaths, brown bars are reported deaths, blue bands are predicted deaths. Bottom-right: time-varying reproduction number (Rt), dark-green 50% CI, light-green 95% CI. |
